Literature DB >> 9142775

Single daily dose of aminoglycosides--a concept whose time has not yet come.

J S Bertino, J C Rotschafer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9142775     DOI: 10.1093/clinids/24.5.820

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  7 in total

1.  Interpretation of antibacterial susceptibility reports: in vitro versus clinical break-points.

Authors:  G W Amsden; J M Duran
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Optimizing therapy with antibacterial agents: use of pharmacokinetic-pharmacodynamic principles in pediatrics.

Authors:  Christopher M Rubino; John S Bradley
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 3.  Clinical pharmacokinetics and pharmacodynamics of isepamicin.

Authors:  M Tod; C Padoin; O Petitjean
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

4.  Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity.

Authors:  M J Rybak; B J Abate; S L Kang; M J Ruffing; S A Lerner; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

5.  Once daily ceftriaxone and gentamicin for the treatment of febrile neutropenia.

Authors:  R J Tomlinson; M Ronghe; C Goodbourne; C Price; J S Lilleyman; S Das; V Saha
Journal:  Arch Dis Child       Date:  1999-02       Impact factor: 3.791

Review 6.  Primary and secondary peritonitis: an update.

Authors:  M Laroche; G Harding
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

Review 7.  Aminoglycosides: nephrotoxicity.

Authors:  M P Mingeot-Leclercq; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.